Solid-phase peptide synthesis experiences efficiency limits and side reactions when synthesizing peptides exceeding certain lengths.
the verdict
SUPPORTED
the evidence backs this
confidence 84/100
Solid-phase peptide synthesis faces well-documented limitations in efficiency and encounters side reactions or aggregation as peptide chain length increases, often requiring specialized strategies for longer sequences.
Evidence for · 4
Overview of Solid Phase Synthesis of “Difficult Peptide” Sequences
2007 · cited by 24
Discusses how certain longer or 'difficult peptides' resist efficient assembly during solid-phase synthesis due to sequence and length limitations.
See more details
More for · 3
Difficult peptides
1999 · cited by 7
Notes that solid-phase peptide synthesis encounters sudden drops in reaction kinetics and incomplete amino-acylation typically 6-12 residues into the assembly of difficult sequences.
Native Chemical Ligation of Peptoid Oligomers.
2026 · cited by 0
Highlights that iterative solid-phase reaction schemes are often limited in their ability to attain protein-like chain lengths, necessitating convergent methods.
Notes that traditional solid-phase peptide synthesis faces efficiency hurdles when constructing larger therapeutic peptides ranging from 30 to 60 amino acids.